Catherine Ibarra-Drendall

Author

Duke Medical Center

Also Known As

C Ibarra-Drendall, Catherine Ibarra-Drendall

Publications

230

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Duke University Duke University Hospital The University of Texas MD Anderson Cancer Center George Mason University

About

Catherine Ibarra-Drendall is an author at Duke Medical Center specializing in breast cancer, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	142
2	Cell Biology	2	2	80
3	Health Sciences	1	1	11
4	Nursing	1	1	38
5	Diabetes	1	1	13

Catherine Ibarra-Drendall

Publications

230

Citations

H-Index

Page 1

	Year	Citations
Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer Shalini Jain, Xiao Wang, Chia‐Chi Chang, Cancer Research Src Kinase BlockadeTumor BiologySrc KinaseBreast OncologyGlucose Metabolism	2015	60
CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis Shauna N. Vasilatos, Gloria Broadwater, William T. Barry, Cancer Epidemiology Biomarkers & Prevention	2009	51
Breast self-examination: defining a cohort still in need Lee G. Wilke, Gloria Broadwater, Sarah Rabiner, The American Journal of Surgery NursingCancer ScreeningBreast ImagingBreast CancerMedicine	2009	38
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways Catherine Ibarra-Drendall, Michelle M. Troch, William T. Barry, Breast Cancer Research and Treatment Proteomic TechnologyTumor BiologyPro-survival PathwaysProspective Proteomic ProfilingMammary Gland	2011	20
Protein Microarray Analysis of Mammary Epithelial Cells from Obese and Nonobese Women at High Risk for Breast Cancer: Feasibility Data Patrick G. Pilié, Catherine Ibarra-Drendall, Michelle M. Troch, Cancer Epidemiology Biomarkers & Prevention	2011	15
Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin? Catherine Ibarra-Drendall, Eric C. Dietze, Victoria L. Seewaldt Current Breast Cancer Reports ObesityMetabolic SyndromeBreast Cancer RiskMetabolic DisorderMedicine	2011	13
<i>ESR1</i> Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention Joseph C. Baker, Julie H. Ostrander, Siya Lem, Cancer Epidemiology Biomarkers & Prevention	2008	12
Ductal Carcinoma In Situ: Challenges, Opportunities, and Uncharted Waters Abigail Hoffman, Catherine Ibarra-Drendall, Virginia Espina, American Society of Clinical Oncology Educational Book Tumor BiologySurgical OncologyTumoral PathologyBreast OncologyMedicine	2012	11
Reproducibility of Random Periareolar Fine Needle Aspiration in a Multi-Institutional Cancer and Leukemia Group B (CALGB) Cross-Sectional Study Catherine Ibarra-Drendall, Lee G. Wilke, Carola M. Zalles, Cancer Epidemiology Biomarkers & Prevention	2009	10

Page 1